APG101 in Myelodysplastic Syndrome
NCT01736436
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndrome
Interventions
DRUG:
Treatment with APG101
PROCEDURE:
Bone marrow collection
PROCEDURE:
Blood drawings
Sponsor
Apogenix GmbH